Welcome to the first information pages dedicated to the new HF pulse device REHATRON™ alpha !
This Website contains information about the "Non-invasive Induction Therapy" device (NIIT) REHATRON™ alpha, which was introduced onto the market in January 2004 after years in development and extensive testing by a team of researchers, engineers and medical professionals.
Based on the large body of documented results from therapy and treatments, as well as the scientific proof of the effects of REHATRON™ alpha and its rapidly spreading fame, we are convinced that this painless, simple and extraordinarily efficient form of therapy will be available to more and more patients in the future.
REHATRON™ alpha is chiefly an auxiliary treatment device for use in the fields of sports medicine, orthopedics and physiotherapy, but it has already been tested successfully against other illnesses and diseases.
Our information pages are directed mainly at physicians and people in other healthcare professions. In these pages, we hope to provide you with a full impression of REHATRON™ alpha, its functional principle and its treatment capabilities. You are invited to request further documentation from us in the "Request for information" area, or to ask specific questions simply by sending an email via the "Contact" link. Naturally, phone calls also welcome.
REHATRON™ alpha is the first device in the class of HF pulse devices (HF stands for high frequency) to be produced in Germany. The manufacturer, Guth, is one of the most respected companies working in high-voltage technology and accordingly is synonymous with the highest quality and technical standards.
If you are interested to learn more about REHATRON™ alpha and its capabilities, it will be worth checking our Web information pages regularly in the near future, because in the next few months we will be constantly posting new facts, data and reports.
We will be glad to answer all your questions and inquiries!
Your REHATRON™ alpha Team
Dear reader,
the A.O.G. GmbH team, our partners and dealers join in wishing you a successful and above all a healthy New Year!
We have many plans for 2006 as well:
The spectrum of possible applications for REHATRON™ alpha is to undergo continued scientific testing and confirmation. At the moment REHATRON™ alpha is the subject of various studies, the first findings of which may be published as early as the second quarter of 2006. With regard to these findings, please understand that for legal reasons these findings can only be published in the password-protected area of this Website, and thus can only be made available to physicians and medical professionals or members of related scientific communities.
Because of the unabated increase in the number of places where REHATRON™alpha is being used, and the corresponding growth in the number of employees, partners and presenters working with REHATRON™ alpha, numerous seminars, symposia and trade fair presentations are planned for 2006 as well. The dates and locations will be posted in the next few weeks in the "Trade Fairs and Seminars" area.
Finally, the next few months REHATRON™ alpha will be introduced operationally throughout Europe and in other parts of the world, and we are looking forward to receiving inquiries from commercial companies and users in many countries - after all, this is the ultimate proof of the immense success of this form of treatment.
If you have questions of any kind whatsoever, please contact us.
A.O.G. GmbH
